Concerning the mechanisms leading to mTOR pathway deregulation, molecular alterations in oncogenes and tumor suppressor genes that are members of the pathway were recently found in lung neuroendocrine neoplasms, but with a relatively low prevalence in carcinoids [10, 11]. Here, MTOR is linked to lung neuroendocrine neoplasm.